Cassava Sciences (SAVA) Stock Forecast & Price Target $26.96 +0.02 (+0.07%) (As of 10/3/2024 ET) Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cassava Sciences - Analysts' Recommendations and Stock Price Forecast (2024) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating Moderate BuyBased on 2 Analyst RatingsSell0Hold1Buy1 Based on 2 Wall Street analysts who have issued ratings for Cassava Sciences in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 2 analysts, 1 has given a hold rating, and 1 has given a buy rating for SAVA. Consensus Price Target $119.00341.39% Upside According to the 2 analysts' twelve-month price targets for Cassava Sciences, the average price target is $119.00. The highest price target for SAVA is $131.00, while the lowest price target for SAVA is $107.00. The average price target represents a forecasted upside of 341.39% from the current price of $26.96. Get the Latest News and Ratings for SAVA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cassava Sciences and its competitors. Enter your email to sign up for newsletter Sign Up SAVA Analyst Ratings Over TimeTypeCurrent Forecast10/5/23 to 10/4/241 Month Ago9/5/23 to 9/4/243 Months Ago7/7/23 to 7/6/241 Year Ago10/5/22 to 10/5/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy1 Buy rating(s)1 Buy rating(s)0 Buy rating(s)1 Buy rating(s)Hold1 Hold rating(s)1 Hold rating(s)1 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)1 Sell rating(s)Consensus Price Target$119.00$119.00$131.00$38.81Forecasted Upside341.39% Upside300.94% Upside1,182.43% Upside189.62% UpsideConsensus RatingModerate BuyModerate BuyHoldHold Safeguard Your Retirement: Avoid the Biden/Harris $4.7 Trillion Tax Hike (Ad)The Biden/Harris War on Your Retirement Savings While the ruling elite have long used tax loopholes to avoid paying their fair share... President Biden and Kamala Harris have unleashed an $80 billion IRS enforcement army of 87,000+ auditors in conjunction with artificial intelligence to aggressively target hard-working Americans' nest eggs.Get Your Free WEALTH PROTECTION GUIDE SAVA Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History SAVA Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Cassava Sciences Stock vs. The CompetitionTypeCassava SciencesMedical CompaniesS&P 500Consensus Rating Score 2.50 2.78 2.50Consensus RatingModerate BuyModerate BuyHoldPredicted Upside341.39% Upside850.32% Upside7.73% UpsideNews Sentiment RatingNeutral NewsSee Recent SAVA NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails8/13/2024HC Wainwright2 of 5 starsV. BernardinoSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral8/8/2024Rodman & Renshaw1 of 5 stars Reiterated RatingBuy ➝ Buy$107.00 ➝ $107.00+286.98%1/25/2023B. Riley4 of 5 starsM. MamtaniSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Target$31.43 ➝ $20.00-4.89%11/29/2022Univest SecSubscribe to MarketBeat All Access for the recommendation accuracy ratingJames JangSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Target$8.57 ➝ $7.86-68.02%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:29 AM ET. SAVA Forecast - Frequently Asked Questions What is Cassava Sciences' forecast for 2024? According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Cassava Sciences is $119.00, with a high forecast of $131.00 and a low forecast of $107.00. Should I buy or sell Cassava Sciences stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cassava Sciences in the last year. There is currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SAVA shares. Does Cassava Sciences's stock price have much upside? According to analysts, Cassava Sciences's stock has a predicted upside of 341.39% based on their 12-month stock forecasts. What analysts cover Cassava Sciences? Cassava Sciences has been rated by research analysts at HC Wainwright, and Rodman & Renshaw in the past 90 days. Do Wall Street analysts like Cassava Sciences more than its competitors? Analysts like Cassava Sciences less than other "medical" companies. The consensus rating score for Cassava Sciences is 2.50 while the average consensus rating score for "medical" companies is 2.78. Learn more on how SAVA compares to other companies. Stock Forecasts and Research Tools Related Companies: Collegium Pharmaceutical Stock Forecast Nature's Sunshine Products Stock Forecast Chimerix Stock Forecast Verrica Pharmaceuticals Stock Forecast Verastem Stock Forecast Fortress Biotech Stock Forecast Blueprint Medicines Stock Forecast Cytokinetics Stock Forecast Krystal Biotech Stock Forecast Organon & Co. Stock Forecast Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Safeguard Your Retirement: Avoid the Biden/Harris $4.7 Trillion Tax Hike (Ad)The Biden/Harris War on Your Retirement Savings While the ruling elite have long used tax loopholes to avoid paying their fair share... President Biden and Kamala Harris have unleashed an $80 billion IRS enforcement army of 87,000+ auditors in conjunction with artificial intelligence to aggressively target hard-working Americans' nest eggs.Get Your Free WEALTH PROTECTION GUIDE This page (NASDAQ:SAVA) was last updated on 10/4/2024 by MarketBeat.com Staff From Our PartnersKamala’s tax plan is worse than you think—find out whyBuffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredTrade Alongside Pelosi, Buffett, and MorePeople don't know that you can trade alongside politicians, lawmakers, and top investors like Warren Buffet, B...Bullseye Trades | SponsoredIs Your 401(k) Kamala-Proof? 5 Critical Moves Before It's Too LateSecure Your Savings from a Kamala Presidency BEFORE the Election Your retirement savings are standing on a ...American Hartford Gold Group | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cassava Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.